circulatory failureとは 意味・読み方・使い方

To obtain a therapeutic agent for internal organs failures that is suitable for curing circulatory failure and internal organs failure in liver, kidney, brain, skin or the like.例文帳に追加

肝臓、腎臓、脳又は皮膚等の循環不全、臓器組織不全等の治療に適した臓器組織不全等の治療剤の提供。 - 特許庁

(c) Peripheral circulatory failure, peripheral nerve disorder, or motive organ disorder of fingers or forearm etc. due to jobs which vibrates the body due to use of equipment or machinery such as rock drills, rivetters, or chain saws発音を聞く 例文帳に追加

３　さく岩機、鋲打ち機、チェーンソー等の機械器具の使用により身体に振動を与える業務による手指、前腕等の末梢循環障害、末梢神経障害又は運動器障害 - 日本法令外国語訳データベースシステム

To provide a medicament useful as a preventing/treating agent or the like of circulatory disease such as heart failure, hypertension and arteriosclerosis based on the strong GRK-inhibiting activity.例文帳に追加

強力なＧＲＫ阻害作用に基づき、心不全・高血圧・動脈硬化等の循環器系疾患の予防・治療剤等として有用な薬剤の提供。 - 特許庁

To obtain a composition excellent in stability, safety and cost for prevention or treatment of diseases related with an alginin vasopressin receptor, such as edema, ascites, renal dysfunction, abnormal vasopressin secretion syndroms, oxytocin-related diseases, hepatocirrhosis, hyponatremia, hypokalemia, diabetes, circulatory failure and obesity.例文帳に追加

安定性、安全性、価格に優れたＡＶＰ受容体に関連する疾患、例えば浮腫、腹水、腎機能障害、バソプレッシン分泌異常症候群、オキシトシン関連、肝硬変、低ナトリウム血症、低カリウム血症、糖尿病、循環不全、肥満などに対する予防又は治療のための組成物を提供すること。 - 特許庁

To provide a pharmaceutical composition capable of exhibiting extremely high therapeutic or prophylactic effects in diseases such as hypertension, edema, ascites, cardiac failure, renal dysfunction, vasopressin secretion abnormality syndrome [syndrome of inappropriate antidiuretic hormone (SIADH)], cirrhosis, hyponatremia, hypopotassemia, polycystic kidney, diabetes, circulatory failure, myocardial infarction and cerebral infarction.例文帳に追加

本発明は、高血圧、浮腫、腹水、心不全、腎機能障害、バソプレシン分泌異常症候群（ＳＩＡＤＨ）、肝硬変、低ナトリウム血症、低カリウム血症、多発性嚢胞腎、糖尿病、循環不全、心筋梗塞、脳梗塞等の疾患において、格段に高い治療又は予防効果を発現し得る医薬組成物を提供することを課題とする。 - 特許庁

The therapeutic agent is effective in treating the circulatory diseases of hypertension, congestive heart failure, angina pectoris, paroxysmal atrial fibrillation, ventricular arrhythmia, sleep apnea syndrome and renal failure; and is the agent for treating, in particular, such hypertension as therapy resistant hypertension, nocturnal hypertension, early-morning hypertension, hypertension accompanied by decreases of lung function and hypertension accompanied by obstructive pulmonary diseases.例文帳に追加

循環器疾患として、高血圧、うっ血性心不全、狭心症、発作性心房細動、心室性不整脈、睡眠時無呼吸症候群及び腎不全に有用な治療薬であり、特に、高血圧として、治療抵抗性高血圧、夜間高血圧、早朝高血圧、肺機能低下を伴う高血圧及び閉塞性肺疾患を伴う高血圧治療薬である。 - 特許庁

To provide a novel compound which has angiotensin II receptor antagonism and PPARγ activating action, and is useful as a preventing and/or therapeutic agent for hypertension, heart disease, angina pectoris, cerebrovascular disorder, cerebral circulation disorder, ischemia nature peripheral circulatory failure, kidney disease, arteriosclerosis, inflammatory disease, 2 type diabetes, diabetic complication, insulin resistance syndrome, syndrome X, metabolic syndrome, and high insulinemia.例文帳に追加

アンジオテンシンII受容体拮抗作用及びＰＰＡＲγ活性化作用を併せ持ち、高血圧症、心疾患、狭心症、脳血管障害、脳循環障害、虚血性末梢循環障害、腎疾患、動脈硬化症、炎症性疾患、２型糖尿病、糖尿病性合併症、インスリン抵抗性症候群、シンドロームＸ、メタボリックシンドローム、高インスリン血症の予防及び／又は治療剤として有用な新規な化合物の提供。 - 特許庁